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Abstract.  The actin filaments of myofibrils are highly 
organized;  they are of a uniform length and polarity 
and are situated in the sarcomere in an aligned array. 
We hypothesized that the barbed-end actin-binding 
protein,  CapZ, directs the process of actin filament as- 
sembly during myofibrillogenesis. We tested this hy- 
pothesis by inhibiting the actin-binding activity of 
CapZ in developing myotubes in culture using two 
different methods. First,  injection of a monoclonal an- 
tibody that prevents the interaction of CapZ and actin 
disrupts the non-striated bundles of actin filaments 
formed during the early stages of myofibril formation 
in skeletal myotubes in culture.  The antibody, when 
injected at concentrations lower than that required for 
disrupting the actin filaments, binds at nascent 
Z-disks.  Since the interaction of CapZ and the mono- 
clonal antibody are mutually exclusive, this result in- 
dicates that CapZ binds nascent Z-disks independent 
of an interaction with actin filaments. In a  second ap- 
proach, expression in myotubes of a mutant form of 
CapZ that does not bind actin results in a delay in the 
appearance of actin in a  striated pattern in myofibrils. 
The organization of ot-actinin  at Z-disks also is 
delayed, but the organization of titin and myosin in 
sarcomeres is not significantly altered.  We conclude 
that the interaction of CapZ and actin is important for 
the organization of actin filaments of the sarcomere. 
TIN filaments of  myofibrils of striated muscle comprise 
part of  one of the most highly ordered macromolecu- 
lar structures found in cells. The mechanism for the 
assembly of actin filaments of the sarcomere requires regula- 
tion of  the location, polarity and length of  the actin filaments, 
as well as coordinated assembly with other components of 
the sarcomere. We hypothesized that the barbed-end actin- 
binding protein, CapZ, functions to organire sarcomeric ac- 
tin filaments by specifying the location of the barbed end of 
actin  filaments,  hence,  specifying the polarity of the actin 
filaments of the I-band. Indirect evidence in support of this 
hypothesis includes:  (a) CapZ and the barbed end of sarco- 
meric actin filaments are located at Z-disks (5,  17, 18); (b) 
there is sufficient CapZ in muscle to bind all the actin fila- 
ments of the sarcomere (30); (c) CapZ can nucleate and cap 
the barbed end of actin  filaments  in vitro (2,  6);  and (d) 
CapZ is assembled at Z-disks of nascent myofibrils before 
the appearance of striated actin filaments in myotubes in cul- 
ture (30).  Together, these data support the idea that CapZ 
functions to organize actin filaments during  sarcomere for- 
mation and to stabilize  actin filaments by preventing  either 
polymerization or depolymerization from the barbed end, 
both of which would alter sarcomere function.  These data 
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also predict that CapZ may bind to nascent Z-disks indepen- 
dent of an association  with actin. 
To obtain direct evidence for the participation  of CapZ in 
organizing  acfin  filaments  during  myofibrillogenesis,  we 
have inhibited  the actin-binding  activity of CapZ in chick 
skeletal muscle myotubes in culture. Inhibition of CapZ was 
accomplished in two ways. In one approach, a monoclonal 
antibody (mAb 1E5) that blocks the interaction  of CapZ and 
actin in vitro was microinjected into chick skeletal  muscle 
myotubes at an early stage of myofibril formation.  Binding 
of mAb IE5 to CapZ inhibits  both the capping and actin- 
nucleating activities of CapZ in vitro (16). In addition,  mAb 
1E5 binds the/51 subunit of CapZ within a region implicated 
to comprise part of the actin-binding  site. In a second ap- 
proach to inhibit CapZ in vivo, we transfected chick muscle 
cultures  with cDNAs that provide expression  of a mutant 
form of the CapZ/31  subunit.  Deletion of 12 amino acids 
from the COOH terminus of the/31 subunit of CapZ removes 
the epitope bound by mAb IE5 and also abrogates the ability 
of CapZ to interact with actin (16). The truncated/31 subunit 
associates with an ot subunit to yield a stable heterodimer 
that is a dominant-negative  mutant form of CapZ. Thus, the 
COOH terminus  of the CapZ/51  subunit is a critical part of 
the actin-binding  site for this actin-binding  protein.  Results 
from both sets of experiments  indicate that alterations  in the 
amount  of functional  CapZ  in  myotubes alter  the  actin 
cytoskeleton and delay the organization  of actin  in sarco- 
meres. 
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All reagents were reagent grade and purchased from Sigma Chem. Co. (St. 
Louis,  MO) or Fisher Scientific Co.  (Pittsburgh,  PA) unless stated other- 
wise.  Fertile chicken eggs were purcha.q~ from Spathos (Roanoke,  IL). 
CapZ was purified from adult chicken pectoralls muscle as described (2). 
Polyclonal goat anti-chicken CapZ was prepared as described (29).  Anti- 
bodies to E. coli B-galactosidase were elicited in rabbits using standard pro- 
tocols by Cocalico Biological Inc. (Reamstown,  PA). Monoclonai antibody 
(mAb) C4, which is specific for actin was a gift of Dr. James Lessard of 
the University of (~inciunati (Cincinnati, OH) (25). mAb EA*53, which is 
specific for sarcomeric c~-actinin  (1D was purchased from Sigma Chem. Co. 
mAb 9D10, which is specific for titin (34) was purchased from the Develop- 
mental Studies Hybridoma Bank at the University of Iowa (Iowa City, IA). 
Cell Culture Methods 
Muscle cell cultures were prepared from lid chick embryos as described 
(27) and maintained in Earle's MEM supplemented with 10% horse serum, 
2.5% chick embryo extract, glutamine, and antibiotics.  Cells were plated 
in 35-ram diam, collagen-coated  plastic dishes at 4  x  105 cells/dish for the 
microinjection experiments or at 5  x  105 cells/dish for the transfection ex- 
periments.  Cultures were  fed fresh media containing  1 /tg/mi cytosine 
arabinoside on the third or fourth day after plating; fresh media without 
cytosine arabinoside was provided on the sixth day after plating. 
Purification of  Antibodies and Microinjection 
mAb IE5 (16), mAb IBll (16), and mouse immunoglobulins  (Sigma Chem. 
Co) were purified on protein A-agerose as described (14). Proteins eluted 
from the protein A-resin were concentrated by addition of an equal volume 
of saturated (NH4)2SO4 followed  by incubation at 4°C  overnight.  The 
precipitated protein was dissolved in a small volume of injection buffer (75 
mM KCI in 10 mM potassium phosphate, pH 7.5) and the proteins were 
dialyzed  against  two changes of injection buffer.  Protein concentrations 
were determined by the method of Bradford (1). Before microinjection, the 
antibody solutions were centrifuged at 100,000 g for 20 rain in a tabletop 
ultracentrifuge. 
Microinjection was performed using a constant flow pipette constructed 
from  a  micrometer  syringe  that  was  guided  by  a  micromanipulator 
(Narishlge, Tokyo, Japan) on a Zeiss Axiovert microscope.  During microin- 
jection, cell cultures were maintained at room temperature in a medium 
containing 10% horse serum in Earle's MEM salt solution buffered at pH 
7.4,  with 20 mM Hepes; this solution also lacked NaI-ICO3 and phenol 
red. To achieve a high concentration of injected antibody, several myotubes 
in a small region of the culture dish were injected at multiple sites along 
the length of each cell. In most experiments,  the concentration of protein 
in the injection pipette was 10 mg/mi; in experiments using low concentra- 
tions of antibody, the protein concentration in the injection pipette was 2 
mg/mi. After microinjection, the normal muscle cell culture medium was 
added and the cultures were returned to the CO2 incubator.  Seven microin- 
jection experiments  were performed using mAb 1E5; four experiments in- 
cluded mouse immunoglobulins as a control and four experiments included 
mAb IBll, which binds the a  subunit of CapZ, but does not inhibit actin 
binding. 
Construction of the RSV-CapZ-IacZ 
Expression Vectors 
The expression vector used in the transfecfion  experiments provides the 
coexpression  of cloned CapZ subunits and B-galactosidase as a marker for 
transfected myotubes under the control of an RSV-LTR promoter.  The par- 
ent vector (pBI-261) used to prepare the DNAs was a generous gift of Dr. 
John Majors of the Deparlment of Biochemistry,  Washington University 
(St. Louis, MO). Situated between the cloned CapZ subunit cDNA and the 
~-galactnsidase cDNA is an internal ribosome entry site from encephalo- 
myocarditis virus that allows ribosomes to bind to uncapped mRNAs (20), 
thus, two polypeptides  are expressed  from a  single mRNA.  "[Yansfected 
myotubes  were identified  by immunolabeling with anti-~-gelactosidase. 
The parent vector,  pBJ-261, was linearized with BstE II and Xba I which 
also excises the gag-neomycin fusion protem cloned into these sites, and the 
CapZ subunit cDNAs were inserted  by blunt-end  llgation  to form the follow- 
ing DNA constructs: pBJ-417, which encodes the full-length ~I subuuit 
(277 amino acids) (3); pBJ-406, which encodes a truncated ~'I subunit that 
lacks 12 amino acids at the COOH terminus of the full-length protein (265 
amino acids) (16); and pBI-410,  which encodes the full-length a2 subunit 
(286 amino acids)  (4).  cDNA expression constructs were purified using 
Maxi-prep columns (Qiagon Inc., Chatsworth, CA) and their concentrations 
were determined by absorbance at 260 nm. 
Transfection Protocol 
Muscle cell cultures were transfected  1 d after plating by the calcium phos- 
phate precipitation method. Briefly, cultures in 35-ram dishes were fed 1.0 
ml fresh medium and incubated for 3  h.  The calcium phosphate-DNA 
precipitate was prepared by mixing equal volumes of freshly prepared 2x 
HSB (280 mM NaC1, 1.5 mM NaHPO4-7H20,  50 mM Hepes, pH 7.1) and 
DNA in 0.248 M CaCI2 so that the final concentration of DNA after addi- 
tion of the 2× HSB is 20/~g/ml. (When a mixture of two DNA constructs 
was used, the final concentration of each DNA was  10 ~tg/ml). Mixing 
of the two solutions was performed by bubbling a  gentle stream of air 
through the 2x HSB while adding dropwise the solution of DNA. After in- 
cubating the mixture at room temperature for 30 rain, 0.125 mi of the DNA 
suspension (2.5/~g DNA) was added dropwise to each 35-ram culture dish; 
cultures were incubated for 5-6 h, and then the DNA suspension was re- 
placed with fresh muscle medium. 
Phalloidin Staining and Immunolabeling of  Muscle 
Cell Cultures 
Cultures to be labeled with pballoidin were fixed according to the following 
method. Cells in 35-mm dishes were rinsed in 30 mM Hepes, pH 7.0, con- 
raining 70 mM KCI, 5 mM MgCI2, and 3 mM EGTA, and fixed for 15 rain 
at room temperature in freshly prepared 2 % paraformaldehyde  in the same 
buffer. Fixed cells were permeab~  by incubation in 0.1% Triton X-100 
in the Hepes  buffer for 15 rain. Cultures to be labeled with mAb C4, to 
identify actin, or mAb EA-53,  to identify ~actinin, were  rinsed in the 
Hepes buffer, and fixed and permeabllized by addition of -20°C methanol 
and incubation at -20°C for 15 min. Fixed cells were blocked in 10% heat- 
inactivated calf serum and 3 % BSA in TTBS (0.3 M NaCI, 20 mM TrisCl, 
pH 7.8, 0.1% vol/vol Tween-20 and 0.01% Na.N3). For microinjection ex- 
periments, cultures were incubated overnight with a  mixture of 33 n_M 
F1TC-phalloidin  (Molecular Probes, Eugene,  OR) and rhodamine~onju- 
gated rabbit anti-mouse IgG (Chemicon, Temecula, CA) at 1:200 dilution. 
Cultures  were washed three times in TTBS and a 22  x  22-ram coversllp 
was applied using 50% (vol/vol) glycerol in 10 mM TrisCl, pH 8.0, contain- 
ing 0.1% n-propylgallate  as mounting medium.  For transfe~on experi- 
ments, cultures were incubated overnight with a mixture of 33 nM Frrc- 
phalloidin and antiserum to ~-galactosidase  at 1:2,000 dilution. Cells were 
washed three times in TTBS and incubated in rhodamine-conjugnted  don- 
key anti-rabbit  lg at 1:200 dilution. Cells were washed three times in TTBS 
and a coverslip  was applied.  For double immtmolabellng  to detect sarco- 
meric ¢x-actiuin  and B-gelactosidase,  mAb EA-53 was used at 1:100 dilution 
and anti-/3-galactosidase  was used at 1:2,000 dilution.  Bound antibodies 
were detected using a mixture of DTAF-conjngated donkey anti-mouse Ig 
at 1:200 dilution and rhodamine-conjugeted  donkey anti-rabbit Ig at 1:200 
dilution. 
Immunofluorescence  microscopy  was performed using a Zeiss Axioplan 
microscope equipped with a 100× (1.3 NA) plan-neoflnar objective and a 
63 x  (1.4 NA) planapechromat objective lens and filters for epifluoresceace 
that excluded  crossover between flunrescein  and rhodamine; the perfor- 
mance of the filters  was confirmed in control experiments.  Photomicro- 
graphs were recorded on Kodak T-max 400 ASA film. In the analysis of the 
transfection  experiments,  an MRC-1000 Laser ScannlnS Confocal Micro- 
scope (BioRad Labs., Hercules,  CA) was used to obtain images at the lower 
surface,  the upper surface  and at a middle focal plane for each myotube. 
Myotubes were first selected based in the expression of ~-galactosidase  and 
confocal images were collected using excitation and emission filters appro- 
priate for detection of FITC-phalloidin.  Confoeal  images were assembled 
as montages using Adobe Photoshop v.  2.5  and printed using a  Kodak 
Colorease Printer. 
Electrophoresis and Immunoblottin$ Procedures 
Total extracts  of the transfected  muscle cultures were prepared using an 
extraction buffer containing 8 M urea, 2 M thiourea, 0.7 M ~-mercapto- 
ethanol, 3 % (wt/vol) SDS, 0.1 mM PMSF, 1/~g/ml leupeptin, I/~M pepsta- 
tin, and 0.1 mM benzamidine in 0.05 M TrisCl,  pH 6.8 (36).  This buffer 
solubilizes  myofibrillar proteins well.  To prepare the extracts,  cells from 
duplicate 35-ram dishes were trypsinized, washed, resuspended in 50 al of 
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at  -70°C until use. Each sample was diluted with 4x  Laemmli sample 
buffer (24) before loading on the gel and equal volumes  of  extract from each 
dish were loaded in each lane. 
Proteins were subjected to electrophoresis in 10% SDS-pulyacrylamide 
gels (24) and transferred  to nitrocellulose (32). Blots were blocked in Super- 
block buffer (Pierce Chemical Co., Rockford, IL) and incubated overnight 
at 4°C with the primary antibodies  diluted in 2 % fish gelatin containing 5 % 
heat-inactivated calf serum in TrBs. Affinity  purified goat anti-CapZ was 
used at 1/~g/rnl  and rabbit antiserum to ~-galactosidase  was used at 1:10,000 
dilution. Blots were washed in TTBS and bound antibodies were detected 
using an appropriate alkaline pbosphatase-conjugeted secondary antibody 
(Tage, Burlinsarne, CA) at 1:10,000 dilution. Blots were washed  with TrBS 
and developed to yield the alkaline pbosphatase reaction product (10). 
Results 
Injection of  mAb 1E5 into Myotubes Alters the 
Distribution of  F-actin in Myotubes 
Binding of mAb 1E5 inhibits CapZ's ability to bind actin in 
vitro (16). To determine the effects of inhibiting CapZ activ- 
ity during myofibrillogenesis in vivo, we injected mAb  1E5 
into chick myotubes developing in culture and observed the 
organization of actin in the myotubes at varying times after 
injection.  One limitation of this approach is that myoblasts 
continue  to  fuse  with  myotubes,  contributing  to increased 
cell volume and consequent decreased concentration  of the 
injected antibody with time after injection. Thus, we injected 
myotubes  on  culture  day  3,  when  myotubes  have  nearly 
reached  their  mature  size  but  do  not  yet  contain  mature 
myofibrils (30). In addition, antibodies at high concentration 
were injected at multiple sites along the length of each myo- 
tube in order to obtain the maximum intracellular concentra- 
tion of antibody. A second limitation is that the injected anti- 
bodies  are  degraded  over  time  in  culture,  and  the  cells 
eventually  recover  as  the  concentration  of  antibody  de- 
creases. Nonetheless,  we observed a  dramatic effect on the 
organization of F-actin in myotubes for up to 24 h after injec- 
tion of  mAb  1E5. 
Three  alterations  of  the  actin  cytoskeleton are  apparent  in 
myotubes 24 h after  injection  with  mAb  IE5 on  culture  day 
3 (Fig.  I,  a-c). In  many cells,  the  non-striated  actin  filament 
bundles which have been called  stress  fiber-like  structures 
(SFLS) (9)  or  premyofibrils  (28),  and are the predominant 
F-actin  structures  in  myotubes at  this  age  in  culture,  are  less 
numerous and  much thinner  than  in  myotubes injected  with 
control mouse immunoglobulins (Fig. I d) or with mAb 
IB11 (data  not  shown),  an  antibody  specific  for  the  a subunit 
of  CapZ that  does  not  inhibit  the  interaction  of  CapZ and  ac- 
tin  in  vitro  (16).  These effects  of  mAb  1E5 on F-actin  were 
observed consistently  in  the majority of  injected  myotubes 
in  seven  different  experiments.  Some  of  the  mAb  1E5- 
injected myotubes were much flatter and wider than control 
mouse immunoglobulin-injected  or uninjected  myotubes at 
this  stage  of  development.  Two  unusual  features  of  the 
F-actin in myotubes injected with mAb  1E5 were observed 
near the upper and lower surfaces of the myotubes.  At the 
lower surface of the injected myotubes, F-actin was in amor- 
phous patches and brightly stained foci (Fig.  1 c) and on the 
upper  surface were numerous  actin-containing  projections 
that resembled microvilli (Fig.  1 b, arrows). Neither of these 
unusual  features  were  observed in  myotubes injected  with 
mouse  immunoglobulins  or  mAb  1Bll.  We  presume  that 
Figure  1. The actin  cytoskeleton  of  young  myotubes is  altered  by 
micminjection  of  inhibitory  mAb IES.  Myotubes  were  injected  on 
culture  day  3  with  either  mAb 1E5  (a-c)  or  mouse  Ig  (d),  and  actin 
was  observed  24  h later.  The  major  form  of  actin  in  control  myo- 
tubes  at  this  stage  of  development  are  non-striated  filament  bundles 
as  observed  in  mouse Ig-injected  myotubes (d).  Few non-striated 
actin  filament  bundles  are  observed  in  the  mAb 1E5-injected  my- 
otubes  (a-c).  Actin  was  in  amorphous  patches  or  bright  loci  near 
the  lower  surface  and  actin-containing  projections  were  observed 
on  the  upper  surface  of  the  myotubes  (arrows  in  b).  Neither  of  these 
unusual  actin-containin~  structures  were  observed  in  myotubes in- 
jected  with  mouse  Ig.  F-actin  was  observed  using  FITC-phaUoidin; 
antibody-injected myotubes were identified by labeling with rhoda- 
mine-conjugated rabbit anti-mouse Ig (not shown). Bar, 20 ~m. 
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many  of which  possessed  mature,  contractile  myofibrils 
yielded a variable effect on the actin cytoskeleton among the 
injected myombes (Fig. 3).  In 28%  of these myombes, the 
effects of injected mAb IE5 on the organization of actin were 
severe and resembled those seen in myotubes injected after 
3  d  in culture  (Fig.  3  a).  Actin filaments were absent or 
fragmented, amorphous, actin-containing patches were ob- 
served near the lower surface of the myombes and microvilli- 
like structures were on the upper surface. However, many of 
these older myotubes appeared relatively unaltered by the 
presence of mAb 1E5 in the cytoplasm (Fig. 3 b); actin was 
Figure 2. The actin cytoskeleton recovered in myotubes by 48 h af- 
ter injection of mAb 1ES. Myotubes were injected on culture day 
3 with either mAb 1E5 (a and b) or mouse Ig (c) and actin was ob- 
served 48 h later.  Non-striated  actin filaments were observed in 
mAb 1E5-injected myotubes but some of the bright foci that stain 
with phaUoidin were still observed. In those myotubes injected with 
mouse Ig, non-striated actin filaments were abundant and some stri- 
ated regions of nascent myofibrils were observed. F-actin was ob- 
served  using  FITC-phalloidin;  antibedy-injected  myotubes were 
identified  by  labeling  with  rhodamine-conjugated  rabbit  anti- 
mouse Ig (not shown). Bar, 20 ttm. 
these F-actin-containing structures form from the actin dis- 
placed from the  non-striated actin filaments that  are nor- 
really abundant in these myotubes. 
By 48 h after injection of mAb 1E5 into myotubes on cul- 
ture day 3, the organization of actin more closely resembled 
that found in uninjected myotubes or in myotubes injected 
with mouse immtmoglobulins (Fig.  2).  Non-striated actin 
filaments formed; some myotubes still possessed the bright 
foci of phalloidin-stained material near the lower surface but 
these features were less apparent than at shorter times after 
antibody injection. Observations longer than 48 h after injec- 
tion of antibody were difficult because, as the injected anti- 
body was degraded, identifcation of the injected cells based 
on  labeling  with  fluorescent  anti-mouse  immunoglobulin 
was often ambiguous. 
Figure 3. Myotubes of 6-d-old muscle cultures were injected with 
either mAb 1E5 (a and b) or mouse Ig (c) and actin was observed 
24 h later.  The actin in some myotubes injected with mAb 1E5 
resembled that seen in myotubes injected on culture day 3; these 
myombes contained few non-striated actin filaments and accumu- 
lated bright foci and amorphous patches of actin (a). Other myo- 
tubes, particularly  those with mature,  striated myofibrillar struc- 
tures,  were not severely affected by the presence of rnAb 1E5 (b) 
and actin was observed in a striated pattern similar to that seen in 
control myotubes injected with mouse Ig (c). The different suscepti- 
bilities of  the myotubes of  older cultures to the effects on the organi- 
zation of ac~ by mAb IE5 likely results from heterogeneity in the 
maturity  of the  myotubes.  F-actin  was  observed  using  F1TC- 
phalloidin; antibody-injected myotubes were identified by labeling 
with rhodamine-conjugated rabbit anti-mouse Ig (not shown). Bar, 
20 ~m. 
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or was detected in a striated pattern (38% of  these myotubes) 
that resembled the distribution of actin in myotubes injected 
with mouse immunoglobulins (Fig. 3 c). However, most of 
these injected myotubes also had actin-rich aggregates near 
their lower surface. The mild or severe effects of mAb 1E5 
injection into these older myotubes may be related to differ- 
ences in the amount of antibody delivered to individual myo- 
tubes, however, this was not apparent from the intensity of 
labeling  with rhodamine-conjugated anti-mouse immuno- 
globulin. Alternatively, because the myotubes in older cul- 
tures are a  heterogeneous population at varying stages of 
differentiation, the stability of the myofibrillar structures to 
mAb 1E5 may vary depending on the maturity of the myo- 
fibrillar structures. Those myotubes susceptible to the anti- 
body may be less mature than those that are more resistant 
to injected mAb  1E5. 
Interaction of CapZ with Nascent Z-Disks 
The fact that the binding of mAb 1E5 blocks CapZ binding 
to actin (16) allowed us to test whether CapZ associates with 
nascent Z-disks independent of an interaction with actin. We 
expected that injected mAb 1E5 would associate with CapZ 
at Z-disks if the CapZ were bound to the Z-disk via an inter- 
action that does not involve actin. When a low concentration 
of mAb 1E5 (fivefold lower than required for disruption of 
F-actin) was injected into 3-d-old myotubes, no significant 
effects on the actin cytoskeleton were observed at 24 h after 
injection (Fig. 4 b). Nonetheless, the intracellular distribu- 
tion of injected mAb 1E5 was instructive. Some of the anti- 
body was found at Z-disks of nascent myofibrils (Fig. 4 a). 
Double  immunolabeling  for  injected mAb  1E5  and  titin 
using mAb 9D10, which binds near the Z-disk domain of  titin 
(ref) confirmed that the periodic structures with bound mAb 
1E5 were Z-disks (data not shown). A similar distribution of 
injected antibody was observed in myotubes of 5-6-d cul- 
tures. Since the interaction of CapZ with actin or mAb 1E5 
in vitro is mutually exclusive, we conclude that at least some 
of the CapZ associated with nascent Z-disks is not yet bound 
to the barbed end of an actin filament and that CapZ interacts 
with other components of the Z-disk during assembly of the 
structure. 
Expression of  Mutant CapZ in Myotubes 
Delays the Appearance of  Atriated Actin l~laments 
of Sarcomeres 
A complementary approach to inhibit CapZ during myofibril 
formation in myotubes in cultures is to express a mutant form 
of CapZ that is unable to bind actin. The advantage of this 
approach over the antibody injection experiments is that the 
efficacy of the inhibitory reagents is not temporary but can 
persist throughout the entire culture period. The mutant pro- 
tein used in these studies was a  truncated form of the/31 
subunit of CapZ. Loss of 12 amino acids from the COOH 
terminus of the/31 subunit results in loss of  actin-binding ac- 
tivity, but retention of  ability to bind an o~ subunit (16). Thus, 
we expect that a fraction of the or/3 heterodimer formed in 
myotubes transfected with the truncated/31-eDNA will be in- 
active. 
Myoblasts  were transfected with eDNA  constructs that 
simultaneously express CapZ subunits and/5-galaetosidase, 
Figure 4. Tim binclins of CapZ to nascent Z-disks is indel~ndent 
of  an interaction with actin, mAb 1E5 was injected at a low concen- 
tration (2 mg/ml in the injection pipette) into myotubes of 3-d cul- 
tures. Myotubes were fixed and stained with fluorescein-conjugated 
rabbit anti-mouse Ig (a) to observe the distribution of  injected anti- 
body and with rhodamine-phaUoidin  to observe F-actin (b). The in- 
jectext  mAb IE5 was detected at l~riodically arrayed structures hav- 
ing the dimensions and spacing identical to that of nascent Z-disks 
(a). There was no significant effect of this concentration of mAb 
1E5 on the distribution of actin in these myotubes (b). Because the 
binding of mAb 1E5 and actin to CapZ is mutually exclusive, this 
finding suggests  that CapZ binds to a component of nascent Z-disks 
independent of an intc~cfion with actin. Bar, 20 tan. 
as a marker for transfected myotubes, under the control of 
an RSV-LTR promoter. The CapZ cDNAs included those en- 
coding the full-length 131 subunit, the mutant/31 subunit that 
lacks  12 amino acids  at the COOH terminus,  and the cx2 
subunit. Additional controls included transfection with vec- 
tor DNA that encodes a viral gag-neo fusion protein in place 
of the CapZ subunit and a mock transfecfion protocol with 
no DNA. Cotransfections using mixtures of the DNAs con- 
raining the ot2-subunit eDNA with either the full-length or 
mutant ~31-subunit cDNAs also were performed. No altera- 
tions in the growth and fusion of myoblasts were observed 
in any of the transfected cultures. By 3 d after transfection, 
nearly all  of the  myotubes expressed the 15-galactosidase 
marker. The high level of transfection efficiency  results from 
the fact that, although not all myoblasts were initially trans- 
fected, all the myotubes that subsequently form contain at 
least  some  nuclei  that  have  incorporated  the  exogenous 
DNA. 
Sehafer et al. Inhibition of CapZ during Myofibrillogenesis  65 Figure 5. Expression of/3-gaiactosidase and of CapZ/3 subunit  in 
muscle  cultures  3  d  (A) and  5  d  after transfecfion  (B).  Equal 
amounts of each culture extract,  prepared as described in Materials 
and Methods, were loaded on a  10% SDS-PAGE gel, transferred 
to nitrocellulose,  and the blots probed with either anti-/3-galactosi- 
dase (upper panel) or goat anti-CapZ (lower panel). The intensity 
of the bands corresponding to the CapZ/5 subunits were similar in 
all culture extracts. The expression of  the mutant 81 subunit in those 
cultures transfected with pBJ-406 is indicated by the faster mobility 
of the truncated protein (lanes 5 and 7); this protein also did not 
react with mAb 1E5, consistent  with the absence of the epitope on 
the mutant 81 subunit  (data not shown)./3-Galactosidase was ex- 
pressed only in transfected  muscle cultures  0anes 3-7) and not in 
control untransfected  or mock-transfected cultures  (lanes I and 2). 
Lanes contain: lane CZ, purified chicken muscle CapZ as standard; 
lane 1, extract  from untransfected  muscle culture; lane 2, extract 
from mock-transfected  muscle culture;  lane 3, extract from culture 
transfected  with a2-subunit cDNA (pBJ-410); lane 4, extract from 
culture transfected  with full-length  81-subunit  cDNA (pBJ-417); 
lane 5,  extract  from culture  transfected  with  mutant 81-subunit 
Analysis by Western blot of  the amounts of/3-galactosidase 
and of the CapZ/3 subunit expressed in the transfected my- 
otubes at 3 d and 5 d of culture is shown in Fig. 5. ~Galac- 
tosidase  was expressed  at  nearly equal  amounts in all  the 
transfected  cultures,  except  in  those  expressing  the  ¢x2 
subunit  or  the  full-length  /3  subunit,  which  was  slightly 
lower. The total amount of CapZ 13 subunit expressed in all 
cultures, as determined by comparing the intensity of bands 
corresponding to the/3  subunits of all the culture extracts, 
was nearly identical (Fig. 5). Thus, the amount of CapZ ex- 
pressed by the transfected myotubes is the amount normally 
expressed by these myotubes in culture and the effects we ob- 
serve on the organization of actin in myotubes are not due 
to elevated levels of CapZ subunits. Expression of  the mutant 
/31 subunit protein that lacks 12 amino acids at its COOH ter- 
cDNA (pBJ-406);  lane 6, extract from culture transfected  with a 
mixture of c~2-subunit and 81-subunit cDNAs (pBJ410+pBJ417), 
lane 7, extract from culture transfected with a mixture of  ix2 subunit 
and mutant 81-subunit cDNAs (pKl-410+pBJ-406). Only the por- 
tion of the blots containing/5-galactosidase  or CapZ/5 subunits are 
shown. Coomassie blue staining of  identical gels verified that simi- 
lar amounts  of protein were loaded in each lane. 
F/gure 6. The actin cytoskeleton in myotubes 3 d after transfection with cDNAs that direct the expression  of the mutant/51  subunit  (a, 
c, and e) and the full-length  81 subunit  (b, d, and f). Confocal microscopy was used to obtain images at three different  focal planes for 
each myotube to visualize the lower surface (a and b), the middle of the myotube (c and d), and the upper surface (e and f). By this time 
in culture,  myotubes expressing the full-length 81 subunit contained some striated actin (d), whereas those expressing the mutant 81 subunit 
were primarily non-striated  (c). Actin also was observed in an amorphous meshwork with some brightly stained foci near the lower surface 
(a) of myombes expressing  the mutant 81 subunit and small actin-rich projections were observed on the upper surface of these myotubes 
(e).  These unusual  F-actin structures  were not observed in myotubes expressing  the full-length  81 subunit.  The distribution  of actin was 
observed using FITC-phalloidin; transfected  myotubes were identified by anti-/3-galactosidase  immunostaining (not shown). Bar,  10 am. 
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(Fig. 5, lanes 5 and 7) and by its lack of reactivity with mAb 
1E5 (data not shown). The results from three independent 
transfection experiments indicated that the amount of mutant 
/31 subunit present in these myotubes is 50-80% of the total 
/5-subunit  protein normally expressed by the myotubes. It is 
likely that the mutant 131 subunit competes with the endoge- 
nous, full-length/31 subunit in binding an ¢x subunit; excess 
/3-subunit  proteins are presumably not stable and are de- 
graded.  The ratio of truncated 131  subunit to endogenous, 
full-length ~1  subunit was higher at 3  d  after transfection 
than at 5 d after transfection (compare lanes 5 and 7 of Fig. 
5, A and B). The change in the relative expression of the ex- 
ogenous mutant/~ subunit may result from an increase in the 
number of untransfected nuclei in myotubes as  myoblasts 
continue to fuse with existing myotubes. 
Myotubes that express the mutant CapZ/~ subunit were 
delayed in the appearance of striated actin filaments. Repre- 
sentative views of the distributions of F-actin in myotubes 
3 d and 5 d after transfection with the mutant/~ subunit and 
with the full-length 13 subunit are shown in Figs. 6 and 7 and 
quantitation of the number of striated myotubes in cultures 
5 d after transfection is presented in Table I. By three days 
after transfection, actin was detected in a partially striated 
pattern in some myotubes transfected with the full-length/31- 
subunlt cDNA (Fig. 6 d).  Only non-striated actin was ob- 
served at this time in culture in myotubes transfected with the 
/31-subunit cDNA (Fig. 6 c). By five days after transfection, 
most myotubes in control cultures had striated actin (Table 
I and Fig. 7 d), whereas most myotubes expressing the mu- 
tant/31 subunit contained either non-striated or partially stri- 
ated F-actin (Table I and Fig. 7 c). Myotubes transfected with 
a mixture of DNAs for the mutant/3 subunit and o~2 subunit 
were similarly delayed in the formation of  mostly striated ac- 
tin; however, the defect was not as severe as in those myo- 
tubes expressing the mutant/3 subunit alone (Table I). 
The unusual F-actin structures observed in myotubes in- 
jected with mAb  1E5 also were observed in myotubes that 
express the mutant/31-subunit protein. Actin was detected in 
a meshwork at the upper and lower surfaces (Fig. 6, a  and 
Figure 7. The actin cytoskeleton in myotubes 5 d after transfection with cDNAs that direct expression of the mutant/31 subunit (a, c, and 
e) and the full-length/~1 subunit (b, d, and f). Confocal microscopy was used to obtain images at three different focal planes for each 
myotube to visualize the lower surface (a and b), the middle (c and d), and the upper surface of myotubes (e and  f). By this time in culture, 
myotubes expressing the full-length/~1 subunit possess I-bands (d), whereas myotubes expressing the mutant ~1 subunit were either non- 
striated or partiully striated (c). Myotubes expressing the mutant/31 subunit also possess actin meshworks and bright foci of actin at their 
lower (a) and upper (e) surfaces. The distribution of actin was observed using FITC-phailoidin; transfected myotubes were identified by 
anti-/~-galactosidase immunostaining (not shown). Bar,  10 t~m. 
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5 d after Transfection with Control  and Mutant CapZ 
~I-Subunit Proteins 
Actin  organization 
only  partially  mostly 
Protein expressed  non-striated  striated  striated 
none  26  %  52  %  22  % 
gag-neo  fusion  39%  27%  34% 
~I subunit  29%  46%  25% 
mutant  B1  subunit  73%  27%  0% 
a2  subunit +  131 
subunit  15 %  53 %  32 % 
c~2 subunit +  mutant 
/51  subunit  49%  44%  7% 
Myotubes in phalloidin-stained cultures 5 d after transfection were scored ac- 
cording to the following criteria.  If only uniformly stained actin filaments were 
observed throughout the length of the myotube, it contained only non-striated 
actin. If at least one region was observed where the actin was in a striated pat- 
tern, it was scored as partially striated. If the majority of the actin in a myotube 
was in a striated pattern, it was scored as mostly striated. Between 100 and 129 
myotubes in each dish were scored, and the percentage of myotubes in each 
class was calculated.  Similar results were obtained if mAb C4 was used to de- 
tect the actin  (not shown). Quantitation of two  independently performed trans- 
fection experiments  yielded similar results. DNA constructs used for exogenous 
protein expression were pBl-261  (gag-neo), pBJ-417 (~1 subuult), pBI-406 (mu- 
tant/51 subuult), and mixtures of pBJ-410 (a2-subuult) and pBJ-417 or pKI-406 
(full-length or mutant 81 subuult). Sample labeled "none" is tabulated from an 
untransfected muscle culture. 
e and Fig. 7 e) and bright, phalloidin-stained foci were ob- 
served at the lower surface of the cells expressing the mutant 
/31-subunit protein (Figs. 6 a  and 7 a). A small number of 
similar phalloidin-stained foci occasionally were observed 
in myotubes of control cultures subjected to the transfection 
protocol, however,  they were especially abundant in those 
myotubes transfected with the mutant /~l-subunit  eDNA. 
Some of the myotubes also formed actin-rich projections on 
their upper surfaces which were observed by transmission 
electron microscopy (data not shown), however, these were 
not as prominent as those observed in myombes injected with 
mAb 1ES. We presume these F-actin-containing structures 
form from actin displaced from sarcomeres by the mutant 
CapZ. 
The delay in the appearance of actin in a striated pattern 
in myotubes 5 d after transfection with the mutant 131 subunit 
also was reflected in the distribution of sarcomeric cx-actinin 
in myotubes by 3 d after transfection (Fig. 8).  Sarcomeric 
oL-actinin was primarily observed at Z-disks in the periodic 
pattern characteristic of mature sarcomeres in control myo- 
tubes or those transfected with the  full-length /31-subunit 
eDNA by this time in culture. The distribution of sarcomeric 
ot-actinin in myotubes expressing the mutant/31 subunit was 
primarily in a stippled pattern. This pattern is typical of the 
distribution of sarcomeric o~-actinin in myotubes at earlier 
times in culture. Thus, the alterations in myofibril assembly 
elicited by a mutant CapZ 131 subunit includes an effect on 
other proteins of the sarcomere that interact with actin. In 
contrast, the distributions of titin and myosin were not dra- 
matically altered by the expression of the mutant/31 subunit 
(data not shown). 
Discussion 
Inhibition of the barbed-end actin-binding protein,  CapZ, 
Figure 8.  The assembly of sarcomerie cL-actinin  at Z-disks was 
delayed in myotubes  expressing the mutant/31 subunit. Sarcomeric 
,~-actinin  was distributed in a stippled, fibrillar pattern in myombes 
3 d after transfection  with pRT-406 (mutant Bl-subunit  eDNA) (a). 
In contrast, by this time in culture, sarcomeri¢ ~-actinin was dis- 
tributed in a striated pattern at nascent Z-disks in myombes  trans- 
fected with pBJ-417 (full-length Bl-subunit eDNA) (b). Confocal 
micrographs were collected at a focal plane through the middle of 
the myotubes.  Sarcomeri¢  a-actinin was detected using mAb EA-53 
and transfected myombes were identified by anti-B-galaetosidase 
immunostaining (not shown). Bar, 10 ~,m. 
during myofibrillogenesis results in a delay in the organiza- 
tion of  actin in I-bands. Similar effects on the actin cytoskele- 
ton of myotubes were observed using two independent ap- 
proaches to  inhibit CapZ-actin binding in vivo:  blocking 
CapZ's interaction with actin using the inhibitory antibody 
mAb 1E5 and expression of a mutant form of CapZ that does 
not bind actin (16). Even though neither approach leads to 
inhibition of all the endogenous CapZ in the myotubes, we 
consistently observed these effects on the organization of ac- 
tin of myofibrils. These  data support the hypothesis that 
CapZ is required for the organization of actin filaments of 
sarcomeres in striated muscles. 
Most significantly, the appearance of striated actin was 
delayed in myotubes expressing a mutant form of CapZ. We 
propose that the delay in the appearance of striated actin 
results from the loss of  actin-binding activity of  CapZ. In our 
hypothesis for myofibrll formation (Fig. 9), the mechanism 
for assembly of polarized actin filaments of I-bands is that 
CapZ binds to nascent Z-disks, and then either nucleates ac- 
The Journal of Cell Biology, Volume 128,  1995  68 Figure 9. Model for the role of CapZ in organizing actin filaments 
during myofibrillogenesis.  This model is based on the experiments 
reported here, together with results of previous experiments (30). 
First, a "molecular template" aligns along the longitudinal axis of 
the myotube in an array that defines the spacing of sarcomeres and 
the sites where Z-disks form. Titin is a likely candidate for this mo- 
lecular template. The orientation of the titin fibrils along the low 
gitudinal axis of the myotube may be guided by either non-striated 
actin filaments or microtubules. CapZ interacts with the template 
at sites where nascent Z-disks form, and then either nucleates actin 
polymerization to form the actin filaments of  the I-band or, alterna- 
tively, CapZ may capture preformed actin filaments and anchor 
them at the Z-disk. Either case would yield an array of actin fila- 
ments with all the barbed end capped and situated at the Z-disk. 
Finally, oeactinin assumes its mature distribution in the sarcomere 
by binding selectively to the region where overlapping, anti-parallel 
actin filaments occur at Z-disks and stabilizes those structures. 
tin polymerization or captures the barbed end of actin fila- 
ments of the non-striated stress fiber-like structures to form 
the actin filaments of the I-band. Capture of actin filaments 
could occur when a reptating or sliding actin filament col- 
lides with CapZ bound at a Z-disk or when a filament elon- 
gating  by polymerization at  its barbed end interacts with 
CapZ at a  Z:disk. 
This hypothesis for CapZ action during myofibriUogenesis 
predicts that CapZ interacts with nascent Z-disks before ac- 
tin of sarcomeres is organized. CapZ is localized at Z-disks 
before actin is observed in a striated pattern (30). Since the 
binding of mAb 1E5 and actin to CapZ are mutually exclu- 
sive  (16),  our observation,  that  injected mAb  1E5  binds 
CapZ at Z-disks, is consistent with the idea that CapZ assem- 
bles at Z-disks independent of its interaction with actin. We 
propose that CapZ binds at nascent Z-disks whose position 
is specified by a molecule that functions as a template for the 
assembly of sarcomeres.  One likely candidate for such a 
template is titin. Titin has been proposed to act as a "molecu- 
lar scaffold" that guides the coordinated assembly of myo- 
fibrillar proteins (12, 26,  33). The alignment of titin in the 
head-to-head, tail-to-tail distribution could define the spac- 
ing of sarcomeres and the positions of nascent Z-disks. Myo- 
sin  thick  filaments  may  organize concomitantly,  perhaps 
guided by interactions with titin (23). The early assembly of 
titin in a  sarcomeric distribution during myofibrillogenesis 
supports this role for titin as a scaffold for the sarcomere (7, 
13,  15, 31,  35). 
A second, though less likely, candidate for binding CapZ 
to Z-disks is nebulin.  Nebulin, however, is one of the last 
myofibrillar proteins to assemble in the distribution seen in 
mature  sarcomeres  (21)  and  also  is  absent  from cardiac 
myofibrils (19), which do contain CapZ, thus, nebulin is nei- 
ther necessary for CapZ binding to Z-disks nor for sarco- 
mere formation. On the other hand, nebulin binding to CapZ 
at a later stage of myofibrillogenesis may serve to correctly 
position the Z-disk domain of nebulin and allow nebulin to 
specify the length of  the thin filaments of skeletal muscle sar- 
comeres (22). 
In addition to slowing the appearance of striated actin in 
myotubes, both experimental approaches resulted in the for- 
marion of unusual F-actin-contalning structures that are not 
normally observed in abundance in muscle cells. We pro- 
pose  that  the  amorphous  patches,  foci,  and  membrane 
projections  that  contain  F-actin  form  because  the  actin 
subunits that would normally assemble as sarcomeric actin 
filaments of I-bands add to other actin structures. Some of 
these displaced actin filaments may enter a degradative path- 
way. Indeed, the numerous, bright, actin-rich foci seen near 
the lower surface of myotubes that  express the mutant/3 
subunit or have been microinjected with mAb 1E5, resemble 
macules, which are proposed to comprise part of a degrada- 
tive pathway for disposal of 13- and 7-actin during myofibril 
formation (8). 
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